- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07484490
Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis
Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy on Sputum Secretion, Dyspnea, and Functional Capacity in Children With Tuberculosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: IMRAN AMJAD, PhD
- Phone Number: 9233224390125
- Email: imran.amjad@riphah.edu.pk
Study Contact Backup
- Name: MUHAMMAD ASIF JAVEED, MS-PT
- Phone Number: 9233224209422
- Email: a.javeed@riphah.edu.pk
Study Locations
-
-
-
Lahore, Pakistan, 54000
- Recruiting
- Gulab Devi Hospital
-
Contact:
- Mashar Hayat, MS-PT
- Phone Number: 03338264018
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Children aged 8 to14 years
- Diagnosed with tuberculosis
- Patients with excessive pulmonary secretions and/or difficulty clearing airway secretions.
- Adequate cognitive ability to understand and follow verbal commands and perform ACBT.
- Informed consent from parent/guardian
Exclusion Criteria:
- Diagnosed with multi-drug-resistant (MDR) TB
- Presence of hemoptysis
- The patient who is unconscious and unresponsive.
- Received physical therapy intervention in the past 2 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active cycle of breathing technique with balloon blowing therapy
(ACBT) are intended to improve ventilation by mobilizing and clearing pulmonary secretions.
ACBT will be administered twice daily, with each session lasting 10 minute for 3 days (25).
It consists of following phases Breathing Control (1-2 min): During this stage, the shoulders and upper chest of participants are relaxed.
With both hands on the abdomen, the patient inhales through the nose and exhales to assist relax the airways through the oral opening.It is used six times.
Thoracic Expansion (3-5 repetitions): During this phase, the patient inhales through their nose, holds it for two to three seconds, and then exhales.
(FET) involves relaxed breathing followed by one or two "huffs" from mid to low lung volumes BALLOON BLOWING THERAPY: child should be upright seating or in a semi-Fowler's position participants will instruct to inhale deeply through the nose and exhale slowly into the balloon with straw
|
ACBT will be administered twice daily, with each session lasting 10 minute for 3 days (25).
It consists of following phases 1. Breathing Control (1-2 min): • In this stage the participants will uses diaphragmatic breathing.
• During this stage, the shoulders and upper chest of participants are relaxed alongside the lower chest to maintain a regular breathing rhythm and tidal volume.
• With both hands on the abdomen, the patient inhales through the nose and exhales to assist relax the airways through the oral opening.
• This method should be used six times.
2. Thoracic Expansion (3-5 repetitions): • During this phase, the patient inhales through their nose, holds it for two to three seconds, and then exhales.
• This phase facilitates airflow and relaxes secretions.
7. The forced expiratory technique (FET) • his involves relaxed breathing followed by one or two "huffs" from mid to low lung volumes to facilitate secretion clearance
|
|
Other: Active cycle of breathing technique
(ACBT) are intended to improve ventilation by mobilizing and clearing pulmonary secretions.
ACBT will be administered twice daily, with each session lasting 10 minute for 3 days (25).
It consists of following phases Breathing Control (1-2 min): During this stage, the shoulders and upper chest of participants are relaxed.
With both hands on the abdomen, the patient inhales through the nose and exhales to assist relax the airways through the oral opening.
This method should be used six times.
Thoracic Expansion (3-5 repetitions): During this phase, the patient inhales through their nose, holds it for two to three seconds, and then exhales.
The forced expiratory technique (FET) involves relaxed breathing followed by one or two "huffs" from mid to low lung volumes to facilitate secretion clearance
|
ACBT will be administered twice daily, with each session lasting 10 minute for 3 days (25).
It consists of following phases 1. Breathing Control (1-2 min): • participants will uses diaphragmatic breathing.
• During this stage, the shoulders and upper chest of participants are relaxed alongside the lower chest to maintain a regular breathing rhythm and tidal volume.
• With both hands on the abdomen, the patient inhales through the nose and exhales to assist relax the airways through the oral opening.
• This method should be used six times.
2. Thoracic Expansion (3-5 repetitions): • During this phase, the patient inhales through their nose, holds it for two to three seconds, and then exhales.
• (FET) is involves relaxed breathing followed by one or two "huffs" BALLOON BLOWING THERAPY: child should be upright seating.
Participants will instruct to inhale deeply through the nose and exhale slowly into the balloon with straw in 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sputum meauring cups
Time Frame: Baeline,3day
|
Sputum volume, the main outcome measure, will measured 24 hours before each treatment. The patients were requested to keep a sputum journal, and the calibrated sputum cups will be used to record the volume of sputum. The total amount of sputum produced over a 24-hour period was noted |
Baeline,3day
|
|
6 minute walk test (6-MWT)
Time Frame: baseline,3day
|
The test is carried out in an inside hallway with colorful tape on the floor marking a 100-foot distance in accordance with a regular procedure. The test's objective was to determine how far the volunteers could walk in six minutes, they were informed. Then, for the next six minutes, they were told to cover as much territory as they could by moving up and down the hallway. The subject could take breaks if they wanted to, and the test was self-paced. |
baseline,3day
|
|
Modified Borg Dyspnea Scale
Time Frame: Baeline,3day
|
The Modified Borg Dyspnea Scale (MBS), a numerical score with a range of 0 to 10, is frequently one of the most often used metrics to evaluate the severity dyspnea .
This vertical scale, which ranges from 0 to 10, provides a personal assessment of exercise intensity.
0 denotes no symptoms, while 10 denotes the highest level of symptoms.
|
Baeline,3day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nayab shahid, MS-PT, RIPHAH INTERNATINAAL UNIVERSITY
Publications and helpful links
General Publications
- Misra A, Pawar R, Pal A. Effect of Balloon-Blowing Exercise on Oxygen Saturation in COVID-19 Patients. Cureus. 2023 Jun 11;15(6):e40250. doi: 10.7759/cureus.40250. eCollection 2023 Jun.
- Aytac S, Ovayolu O, Dogru S. The effect of breathing exercises on fatigue in tuberculosis patients: a randomized controlled trial. Rev Assoc Med Bras (1992). 2024 Dec 2;70(12):e20240888. doi: 10.1590/1806-9282.20240888. eCollection 2024. Erratum In: Rev Assoc Med Bras (1992). 2025 Jan 20;71(1):e20240888ERRATUM. doi: 10.1590/1806-9282.20240888ERRATUM.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Signs and Symptoms, Respiratory
- Gram-Positive Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Actinomycetales Infections
- Mycobacterium Infections
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Tuberculosis
- Dyspnea
Other Study ID Numbers
- REC/RCR&AHS/NAYAB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tuberculosis
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Beijing Chest HospitalHuashan Hospital; National Medical Center for Infectious DiseasesNot yet recruitingTuberculosis | Drug-resistant Tuberculosis | Pulmonary Tuberculosis | Rifampicin Resistant TuberculosisChina
-
Universiteit AntwerpenAurum Institute; University of Stellenbosch; University of the Free State; Free...RecruitingDrug-resistant Tuberculosis | Rifampicin Resistant Tuberculosis | Pulmonary Tuberculoses | Multidrug Resistant TuberculosisSouth Africa
-
Assistance Publique - Hôpitaux de ParisCompletedExtrapulmonary Tuberculosis | Lymph Node Tuberculosis | Bone TuberculosisFrance
-
Centers for Disease Control and PreventionBoston University; Pfizer; Columbia University; University of Texas; University of... and other collaboratorsCompletedMulti-Drug Resistant Tuberculosis | Extensively Drug Resistant TuberculosisSouth Africa
-
University of Cape TownUniversity of Stellenbosch; University of Cape Town Lung Institute; University... and other collaboratorsCompletedTuberculosis | Multidrug Resistant Tuberculosis | Extensively-drug Resistant TuberculosisSouth Africa
-
Huashan HospitalThe Hong Kong Polytechnic UniversityNot yet recruitingPulmonary Tuberculosis | Tuberculosis (TB) | Tuberculosis ActiveChina
-
Shandong UniversityShandong Public Health Clinical CenterNot yet recruiting
-
Huashan HospitalBeijing Chest HospitalActive, not recruitingDrug-resistant Tuberculosis | Pulmonary Tuberculosis | Rifampin-resistant TuberculosisChina
Clinical Trials on Active Cycle of breathing
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
Riphah International UniversityCompletedBreathing ExercisesPakistan
-
Maltepe UniversitySaglik Bilimleri UniversitesiCompleted
-
Superior UniversityRecruiting
-
Mansoura UniversityCompletedEffect of the Active Cycle of Breathing Technique on Coronary Artery Bypass Graft Patients' OutcomesCoronary Artery Bypass | Coronary Arterial Disease (CAD)Egypt
-
Riphah International UniversityRecruiting
-
Riphah International UniversityCompletedShortness of BreathPakistan
-
Chungbuk National University HospitalTrudell Medical InternationalNot yet recruitingBronchiectasis | Bronchiectasis With Acute ExacerbationKorea, Republic of
-
Riphah International UniversityRecruiting
-
Cairo UniversityCompletedCorona Virus InfectionEgypt